Access cutting-edge myelodysplastic syndromes treatment through this clinical trial at a research site in Eugene. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Eugene location
Access myelodysplastic syndromes specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myelodysplastic syndromes treatment provided free
Check if you qualify for this myelodysplastic syndromes clinical trial in Eugene, OR
No-Cost Study Care
Local to Eugene
Convenient for OR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study will enroll participants with myelodysplastic syndromes (MDS) with an Isocitrate dehydrogenase protein, 1 (IDH1) mutation, who have not received treatment with a hypomethylating agent previously. Participants will be randomized to receive either ivosidenib (IVO) alone or azacitidine (AZA) alone. IVO will be administered daily throughout the 28-day treatment cycle and AZA will be administered for the first 7 days of each 28-day cycle. Study visits will be conducted every week during Cy
Sponsor: Institut de Recherches Internationales Servier
Yes, this clinical trial (NCT06465953) has an active research site in Eugene, OR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for myelodysplastic syndromes treatment options in Eugene, OR, this clinical trial (NCT06465953) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Eugene research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myelodysplastic syndromes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all myelodysplastic syndromes clinical trials near you to find additional studies recruiting in your area.
See all myelodysplastic syndromes clinical trials recruiting in Eugene — not just this study.
Browse Myelodysplastic Syndromes Trials in Eugene →